You are here

Article Text

Article menu
Download PDFPDF
Letter
First case of spectinomycin resistant Neisseria gonorrhoeae Isolate in New Delhi, India
  1. M Bala1,
  2. K Ray1,
  3. S Salhan2
  1. 1Regional STD Teaching, Training and Research Centre, Vardhman Mahavir Medical College and Safdarjang Hospital, New Delhi, India
  2. 2Department of Obstetrics and Gynaecology, Vardhman Mahavir Medical College and Safdarjang Hospital, New Delhi, India
  1. Correspondence to:
 Dr Manju Bala
 Sector 13, Block J, Q No 4/1, M S Flats, R K Puram, New Delhi, 110022; manjubala_2hotmail.com

https://doi.org/10.1136/sti.2004.011569

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Spectinomycin is recommended as an alternative antimicrobial in CDC treatment guidelines of uncomplicated gonococcal infection.1 There are reports available on spectinomycin resistant Neisseria gonorrhoeae isolates from China, Philippines, and Sri Lanka but no resistance has been reported from India and other South East Asia Region countries such as Bangladesh, Thailand, and Indonesia.2 To our knowledge, this is the first report of spectinomycin resistant N gonorrhoeae from India.

    A 21 year old female patient with a history of vaginal discharge for the past month, attended the gynaecology outpatient department of Safdarjung Hospital in August 2002. On speculum …

    View Full Text